• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏热消融治疗肝细胞癌和结直肠癌肝转移患者的长期疗效与空间特征和肿瘤特异性变量相关。

Long-term results of liver thermal ablation in patients with hepatocellular carcinoma and colorectal cancer liver metastasis regarding spatial features and tumor-specific variables.

机构信息

Hacettepe University Faculty of Medicine, Department of Radiology, Ankara, Türkiye

Hacettepe University Faculty of Medicine, Department of Biostatistics, Ankara, Türkiye

出版信息

Diagn Interv Radiol. 2024 May 13;30(3):183-192. doi: 10.4274/dir.2023.221986. Epub 2023 Mar 20.

DOI:10.4274/dir.2023.221986
PMID:36994643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11095064/
Abstract

PURPOSE

Colorectal cancer liver metastasis (CRLM) and hepatocellular carcinoma (HCC) are widely treated using microwave and radiofrequency ablation. Local tumor progression (LTP) may develop depending on the shortest vascular distance and large lesion diameter. This study aims to explore the effect of these spatial features and to investigate the correlation between tumor-specific variables and LTP.

METHODS

This is a retrospective study covering the period between January 2007 and January 2019. One hundred twenty-five patients (CRLM: HCC: 64:61) with 262 lesions (CRLM: HCC: 142:120) were enrolled. The correlation between LTP and the variables was analyzed using the chi-square test, Fischer's exact test, or the Fisher-Freeman-Halton test where applicable. The local progression-free survival (Loc-PFS) was analyzed using the Kaplan-Meier method. Univariable and multivariable Cox regression analyses were performed to identify prognostic factors.

RESULTS

Significant correlations were observed for LTP in both CRLM and HCC at a lesion diameter of 30-50 mm ( = 0.019 and < 0.001, respectively) and SVD of ≤3 mm ( < 0.001 for both). No correlation was found between the ablation type and LTP (CRLM: = 0.141; HCC: = 0.771). There was no relationship between residue and the ablation type, but a strong correlation with tumor size was observed ( = 0.127 and < 0.001, respectively). In CRLM, LTP was associated with mutant K-ras and concomitant lung metastasis ( < 0.001 and = 0.003, respectively). In HCC, a similar correlation was found for Child-Pugh B, serum alpha-fetoprotein (AFP) level of >10 ng/mL, predisposing factors, and moderate histopathological differentiation ( < 0.001, = 0.008, = 0.027, and < 0.001, respectively). In CRLM, SVD of ≤3 mm proved to be the variable with the greatest negative effect on Loc-PFS ( = 0.007), followed by concomitant lung metastasis ( = 0.027). In HCC, a serum AFP level of >10 ng/mL proved to be the variable with the greatest negative effect on Loc-PFS ( = 0.045).

CONCLUSION

In addition to the lesions' spatial features, tumor-specific variables may also have an impact on LTP.

摘要

目的

结直肠癌肝转移(CRLM)和肝细胞癌(HCC)广泛采用微波和射频消融治疗。局部肿瘤进展(LTP)可能因最短血管距离和大病灶直径而发生。本研究旨在探讨这些空间特征的影响,并研究肿瘤特异性变量与 LTP 的相关性。

方法

这是一项回顾性研究,涵盖了 2007 年 1 月至 2019 年 1 月期间的病例。共纳入 125 例患者(CRLM:HCC:64:61),共 262 个病灶(CRLM:HCC:142:120)。采用卡方检验、Fisher 精确检验或 Fisher-Freeman-Halton 检验分析 LTP 与变量之间的相关性,适用时。采用 Kaplan-Meier 法分析局部无进展生存期(Loc-PFS)。采用单变量和多变量 Cox 回归分析确定预后因素。

结果

在病灶直径为 30-50mm( = 0.019 和 < 0.001)和 SVD ≤3mm(均 < 0.001)时,CRLM 和 HCC 中均观察到 LTP 有显著相关性。消融类型与 LTP 之间无相关性(CRLM: = 0.141;HCC: = 0.771)。残基与消融类型之间无关系,但与肿瘤大小有很强的相关性( = 0.127 和 < 0.001)。在 CRLM 中,LTP 与突变型 K-ras 和伴发肺转移有关(均 < 0.001)。在 HCC 中,类似的相关性也存在于 Child-Pugh B、血清 alpha-fetoprotein(AFP)水平>10ng/ml、诱发因素和中组织病理学分化(均 < 0.001)。在 CRLM 中,SVD ≤3mm 是对 Loc-PFS 影响最大的变量( = 0.007),其次是伴发肺转移( = 0.027)。在 HCC 中,血清 AFP 水平>10ng/ml 是对 Loc-PFS 影响最大的变量( = 0.045)。

结论

除病灶的空间特征外,肿瘤特异性变量也可能对 LTP 产生影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/11095064/fe6cec2b9d97/DIR-30-183-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/11095064/a322e1c8eb37/DIR-30-183-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/11095064/8042729f441a/DIR-30-183-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/11095064/c0dbdb75b5ad/DIR-30-183-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/11095064/db6ec5263d03/DIR-30-183-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/11095064/fe6cec2b9d97/DIR-30-183-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/11095064/a322e1c8eb37/DIR-30-183-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/11095064/8042729f441a/DIR-30-183-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/11095064/c0dbdb75b5ad/DIR-30-183-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/11095064/db6ec5263d03/DIR-30-183-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/11095064/fe6cec2b9d97/DIR-30-183-g5.jpg

相似文献

1
Long-term results of liver thermal ablation in patients with hepatocellular carcinoma and colorectal cancer liver metastasis regarding spatial features and tumor-specific variables.肝脏热消融治疗肝细胞癌和结直肠癌肝转移患者的长期疗效与空间特征和肿瘤特异性变量相关。
Diagn Interv Radiol. 2024 May 13;30(3):183-192. doi: 10.4274/dir.2023.221986. Epub 2023 Mar 20.
2
MR-guided microwave ablation of hepatocellular carcinoma (HCC): is general anesthesia more effective than local anesthesia?MR 引导下微波消融治疗肝细胞癌(HCC):全身麻醉是否比局部麻醉更有效?
BMC Cancer. 2021 May 17;21(1):562. doi: 10.1186/s12885-021-08298-2.
3
Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.射频消融治疗肝细胞癌作为一线治疗:162 例肝硬化患者的长期结果和预后因素。
Radiology. 2014 Mar;270(3):900-9. doi: 10.1148/radiol.13130940. Epub 2013 Oct 30.
4
Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.更新的经皮射频消融作为单一肝细胞癌 < 3cm 的一线治疗 10 年结果:强调局部肿瘤进展与总生存的关系。
Eur Radiol. 2020 Apr;30(4):2391-2400. doi: 10.1007/s00330-019-06575-0. Epub 2020 Jan 3.
5
Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance.超声引导下经皮微波消融治疗结直肠癌肝转移患者癌胚抗原水平的预后价值
Medicine (Baltimore). 2018 Mar;97(10):e0044. doi: 10.1097/MD.0000000000010044.
6
3D visualization ablation planning system assisted microwave ablation for hepatocellular carcinoma (Diameter >3): a precise clinical application.3D 可视化消融规划系统辅助微波消融治疗直径 >3cm 的肝癌:精准的临床应用。
BMC Cancer. 2020 Jan 20;20(1):44. doi: 10.1186/s12885-020-6519-y.
7
SAGES/AHPBA guidelines for the use of microwave and radiofrequency liver ablation for the surgical treatment of hepatocellular carcinoma or colorectal liver metastases less than 5 cm.SAGES/AHPBA关于使用微波和射频肝消融术治疗直径小于5厘米的肝细胞癌或结直肠癌肝转移瘤的手术治疗指南。
Surg Endosc. 2023 Dec;37(12):8991-9000. doi: 10.1007/s00464-023-10468-1. Epub 2023 Nov 13.
8
A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation.一种用于预测早期肝细胞癌患者微波消融后局部肿瘤进展的新诺莫图:一种预测消融成功的工具。
Cancer Med. 2020 Jan;9(1):104-115. doi: 10.1002/cam4.2606. Epub 2019 Nov 12.
9
Efficacy and Safety of Local Liver Radioablation in Hepatocellular Carcinoma Lesions within and beyond Limits of Thermal Ablation.局部肝脏放射消融治疗肝癌病灶在热消融范围内外的疗效和安全性。
Dig Dis. 2024;42(5):461-472. doi: 10.1159/000538788. Epub 2024 May 23.
10
Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.多电极交换式经皮射频消融治疗早期肝癌后复发的危险因素:多中心前瞻性研究。
Int J Hyperthermia. 2022;39(1):190-199. doi: 10.1080/02656736.2021.2024279.

引用本文的文献

1
A Post-International Gastrointestinal Cancers' Conference (IGICC) Position Statements.一篇国际胃肠道癌症会议(IGICC)的立场声明。
J Hepatocell Carcinoma. 2024 May 29;11:953-974. doi: 10.2147/JHC.S449540. eCollection 2024.

本文引用的文献

1
Implications of RAS Mutations on Oncological Outcomes of Surgical Resection and Thermal Ablation Techniques in the Treatment of Colorectal Liver Metastases.RAS突变对手术切除和热消融技术治疗结直肠癌肝转移瘤肿瘤学结局的影响
Cancers (Basel). 2022 Feb 5;14(3):816. doi: 10.3390/cancers14030816.
2
Consensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN Initiative.图像引导肿瘤消融中时间事件终点定义的共识指南:SIO 和 DATECAN 倡议的结果。
Radiology. 2021 Dec;301(3):533-540. doi: 10.1148/radiol.2021203715. Epub 2021 Sep 28.
3
Prospective double-blinded randomized controlled trial of Microwave versus RadioFrequency Ablation for hepatocellular carcinoma (McRFA trial).
微波与射频消融治疗肝细胞癌的前瞻性双盲随机对照试验(McRFA试验)
HPB (Oxford). 2020 Aug;22(8):1121-1127. doi: 10.1016/j.hpb.2020.01.008. Epub 2020 Feb 8.
4
Tailoring ablation strategies for colorectal liver metastases based upon rat sarcoma viral oncogene mutation status.根据大鼠肉瘤病毒致癌基因突变状态制定结直肠癌肝转移的消融策略。
Chin Clin Oncol. 2019 Oct;8(5):51. doi: 10.21037/cco.2019.08.05. Epub 2019 Sep 6.
5
Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis.微波消融与射频消融治疗肝细胞癌和肝转移瘤的比较:一项系统评价和荟萃分析。
Onco Targets Ther. 2019 Aug 13;12:6407-6438. doi: 10.2147/OTT.S204340. eCollection 2019.
6
The value of KRAS gene status in predicting local tumor progression of colorectal liver metastases following radiofrequency ablation.KRAS 基因状态在预测结直肠肝转移瘤射频消融后局部肿瘤进展中的价值。
Int J Hyperthermia. 2019 Jan;36(1):211-219. doi: 10.1080/02656736.2018.1556818. Epub 2019 Jan 21.
7
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南:肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
8
Does the Site of the Primary Affect Outcomes When Ablating Colorectal Liver Metastases with Radiofrequency Ablation?使用射频消融术切除结直肠癌肝转移灶时,原发灶部位会影响预后吗?
Cardiovasc Intervent Radiol. 2018 Jun;41(6):912-919. doi: 10.1007/s00270-018-1937-9. Epub 2018 Mar 26.
9
Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial.微波消融与射频消融治疗慢性肝病患者肝细胞癌的疗效比较:一项随机对照 2 期试验。
Lancet Gastroenterol Hepatol. 2018 May;3(5):317-325. doi: 10.1016/S2468-1253(18)30029-3. Epub 2018 Mar 2.
10
Understanding the nuances of microwave ablation for more accurate post-treatment assessment.理解微波消融的细微差别,以更准确地进行治疗后评估。
Future Oncol. 2018 Jul;14(17):1755-1764. doi: 10.2217/fon-2017-0736. Epub 2018 Feb 14.